Health & Medicine
Eli Lilly's Diabetes Drug Approval Halted by FDA over Facility Quality Issues
The U.S Food Administration declined to approve Eli Lilly's new diabetes drug empagliflozin, citing quality issues at the German factory where the drug will be made, Lilly along with its partner Boehringer Ingelheim said Wednesday.
Latest Research Articles
I'll Have What He's Having: Drinking Pals Mimic Alcoholic Drink Orders
Anger Outbursts Linked with Higher Heart Disease, Stroke Risk
Studies Uncover Mental Health Problems, Suicide Risk in Army
Smoking Tied with Structural Changes in Teen Brains
Researchers Revive 30,000-Year-Old Giant Virus Frozen in Siberia
Rare Mutations Reduce Diabetes Type-2 Risk
Activating Protein Sirtuin 1 Improves Health, Extends Lifespan in Mice
People with Insomnia have Hyperactive Brains
Childhood Nightmares Linked to Mental Problems in Adolescence
Hand Sanitizer Not Available Enough at 1 in 5 US Hospitals
Obesity Rates in Young US Children Down 43 Percent
Marijuana Legalization Likely to Result in More US High School Students Getting High
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
